Number of the records: 1

COVID-19

Subject h.	COVID-19
Subject h.	COVID-19
Entry terms	ochorenie spôsobené novým koronavírusom 2019 ochorenie novým koronavírusom 2019 infekcia novým koronavírusom 2019 ochorenie 2019-nCoV infekcia 2019-nCoV pandémia COVID-19 ochorenie vírusom COVID-19 ochorenie COVID-19, vírusové infekcia vírusom COVID-19 infekcia COVID-19, vírusová ochorenie koronavírusom 2019 ochorenie koronavírusom-19 infekcia koronavírusom SARS 2 SARS-CoV-2 infekcia COVID19
English X references	2019 Novel Coronavirus Disease 2019 Novel Coronavirus Infection 2019-nCoV Disease 2019-nCoV Infection COVID-19 Pandemic COVID-19 Pandemics COVID-19 Virus Disease COVID-19 Virus Infection Coronavirus Disease 2019 Coronavirus Disease-19 SARS Coronavirus 2 Infection SARS-CoV-2 Infection Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Scope note in English	A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
See also reference (FX) in Slovak	SARS-CoV-2
See also reference (FX) in English	SARS-CoV-2
Links	(884) - ARTICLES
	(1) - MeSH descriptor
	(97) - CiBaMed
	(66) - ELECTRONIC RESOURCES
	(21) - BOOKS

subject heading

Number of the records: 1